Community Practice

Many FDA-approved drugs on the market are available in multiple product formulations; it's critical for pharmacists to recognize these differences.

This fall there are a host of new products to treat lice and there are many companies that are currently working on new treatments.

Skin cancer diagnoses are on the rise with more than one million cases of skin cancer diagnosed in the U.S. this year. But despite the statistics, only a handful of late-stage agents remain in development for metastatic melanoma.

Drug Topics covers the emerging AIDS crisis as hope for drug treatment and vaccines rise.

There is still inadequate communication among pharmacists from different practice settings about patients' medications. Pharmacists should take ownership of medication reconciliation.

Changes to formularies continue to be among the most frustrating aspects of the Medicare prescription drug benefit for pharmacists and physicians, and most confusing to beneficiaries.

Insurers cut back on coverage of bioidentical hormone replacement therapy.

Pseudoephedrine tracking systems improve on the log book to reduce burden on pharmacies and help law enforcement.

Drug therapies for Alzheimer's disease, have the ability to reduce functional and cognitive decline but don't necessarily work for all patients.

Ambrisentan (Letairis) from Gilead Sciences, Inc. has been approved by the FDA for patients with PAH (WHO Group 1) with WHO Functional Class II or III symptoms.

Vital Care is a franchise that has offered specialty pharmacy through community pharmacies for years.

HealthMatics ED system is a software application that automates an emergency department, from patient tracking to clinical documentation.

Smart pumps must be part of a smart system to actually boost patient safety and improve outcomes.

Inviro Medical Devices has introduced an integral write-on stripe, Invirostripe, to its complete line of manually retractable InviroSNAP! safety syringes.

Aromatherapy is a complementary and alternative medicine offering patients of a large Indianapolis health system some relief from the stress associated with chronic illnesses, including cancer, and women's health issues.

ASHP had devloped a draft of proposals to Joint Commission.

Patient takes tramadol 100 mg every six hours for chronic back pain; other medications include two lithium carbonate, extended release tablets, ziprasidone, temazepam, and trazodone.

Controversy surrounding rosiglitazone (Avandia) and cardiac risk prompted a special symposium at the annual scientific sessions of the American Diabetes Association.

Developing a program to prevent over-prescribing of antibiotics will increase effectiveness of the drugs and save money.

Researchers at the American Society of Clinical Oncology meeting stressed that treatment more targeted, with fewer side effects, than before - and cancer deaths are down for the first time in 70 years.

Pharmacists react to final rule for average manufacturers price rule for Medicaid generic drug reimbursement.

The complaint cited several examples of discrimination, including allegations that African-American employees were passed over for promotions to management positions in spite of experience, seniority, and qualifications.

Among the provisions, physicians will have to report hemoglobin or hematocrit data on claims for antianemia drugs for cancer patients.

Like the Senate, the House has passed a bill that would give the FDA more authority to ensure drug safety by requiring manufacturers to conduct postmarketing surveillance studies; demand more user fees; and other measures.

Walgreen Co. has reached an agreement to purchase specialty pharmacy operator Option Care Inc. for about $850 million. Option Care, based in Buffalo Grove, Ill., provides a full spectrum of specialty-pharmacy and home-infusion services